Company intelligence / Profile preview

Nanologica

Södertälje, Sweden
Ownership
Private
Employees
~16
Development stage
Other
01

Overview

Nanologica is a commercial life science tools company supplying silica-based media and columns for preparative and analytical chromatography, especially for purification of peptide drugs such as insulin and GLP‑1 analogues, used by pharmaceutical manufacturers globally for diabetes and obesity drug production.[1][3][4][6]

Therapeutic areas
Endocrinology
Modalities
Small moleculePeptidesNanoparticle
Industry
Chemicals & Materials
02

Partnerships

Contract manufacturing partner in the UK and Ireland for large‑scale silica production[6]

Beyond the preview

Go deeper on Nanologica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanologica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call